Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1142 0 |
SM ISO690:2012 STĂNESCU, Alexandra Ana Maria, STEFANI, Constantin, GRAJDEANU, Ioana Veronica, SERBAN, Bogdan, CIOBANU, Gheorghe, DIACONU, Camelia. Severity of psoriasis associated with metabolic syndrome. In: Revista de Chimie, 2019, nr. 6(70), pp. 2072-2079. ISSN 0034-7752. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Revista de Chimie | |
Numărul 6(70) / 2019 / ISSN 0034-7752 | |
|
|
Pag. 2072-2079 | |
Rezumat | |
Although extensively studied, psoriasis still has negative consequences and is associated with multiple comorbidities, including metabolic syndrome. The severity of psoriasis seems to influence the occurrence of diagnostic criteria for metabolic syndrome. 208 patients diagnosed with psoriasis were identified, who were divided into lots depending on the severity of psoriasis, but also to the presence or absence of metabolic syndrome. Interpretation of statistical data was done with SPSS V21 (Statistical Package for Social Science) and MEDCALC (Statistical Software). The coexistence of severe psoriasis with metabolic syndrome increases the risk of developing cardiovascular diseases by 2.97 or greater, with a confidence interval of [1.60, 5.51], than that of patients with severe psoriasis who have no metabolic syndrome. The hypothesis was statistically confirmed by p = 0.003. Analyzing the total group with psoriasis by severity, we found the following distribution: From the total number of 208 patients, 39 (18.8%) had severe psoriasis, 83 (39.9%) moderate psoriasis and 86 (41.3%) mild psoriasis. The higher incidence of metabolic syndrome in patients with psoriasis is evidenced by the Pearson Chi-Square test, where p <0.001. The association of metabolic syndrome in patients with psoriasis is evident. The more severe the psoriasis, the more likely it is to develop metabolic syndrome. |
|
Cuvinte-cheie cardiovascular diseases, metabolic syndrome, psoriasis |
|
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <creators> <creator> <creatorName>Stănescu, A.</creatorName> <affiliation>Universitatea de Medicină şi Farmacie „Carol Davila“, România</affiliation> </creator> <creator> <creatorName>Stefani, C.</creatorName> <affiliation>Universitatea de Medicină şi Farmacie „Carol Davila“, România</affiliation> </creator> <creator> <creatorName>Grajdeanu, I.</creatorName> <affiliation>Universitatea de Medicină şi Farmacie „Carol Davila“, România</affiliation> </creator> <creator> <creatorName>Serban, B.</creatorName> <affiliation>Universitatea de Medicină şi Farmacie „Carol Davila“, România</affiliation> </creator> <creator> <creatorName>Ciobanu, G.C.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Diaconu, C.</creatorName> <affiliation>Universitatea de Medicină şi Farmacie „Carol Davila“, România</affiliation> </creator> </creators> <titles> <title xml:lang='en'>Severity of psoriasis associated with metabolic syndrome</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2019</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>0034-7752</relatedIdentifier> <subjects> <subject>cardiovascular diseases</subject> <subject>metabolic syndrome</subject> <subject>psoriasis</subject> </subjects> <dates> <date dateType='Issued'>2019-06-03</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p>Although extensively studied, psoriasis still has negative consequences and is associated with multiple comorbidities, including metabolic syndrome. The severity of psoriasis seems to influence the occurrence of diagnostic criteria for metabolic syndrome. 208 patients diagnosed with psoriasis were identified, who were divided into lots depending on the severity of psoriasis, but also to the presence or absence of metabolic syndrome. Interpretation of statistical data was done with SPSS V21 (Statistical Package for Social Science) and MEDCALC (Statistical Software). The coexistence of severe psoriasis with metabolic syndrome increases the risk of developing cardiovascular diseases by 2.97 or greater, with a confidence interval of [1.60, 5.51], than that of patients with severe psoriasis who have no metabolic syndrome. The hypothesis was statistically confirmed by p = 0.003. Analyzing the total group with psoriasis by severity, we found the following distribution: From the total number of 208 patients, 39 (18.8%) had severe psoriasis, 83 (39.9%) moderate psoriasis and 86 (41.3%) mild psoriasis. The higher incidence of metabolic syndrome in patients with psoriasis is evidenced by the Pearson Chi-Square test, where p <0.001. The association of metabolic syndrome in patients with psoriasis is evident. The more severe the psoriasis, the more likely it is to develop metabolic syndrome.</p></description> </descriptions> </resource>